Palantir patient data tech rejected by many NHS trusts in England

סיכום מאמר

Palantir’s patient‑data platform, designed to integrate and analyse health information across the NHS, has been turned down by a majority of NHS trusts in England. An exclusive survey of health bodies nationwide reveals widespread concerns over patient privacy, data security and the potential for commercial exploitation of sensitive medical records. Trusts cite insufficient transparency about how Palantir stores, accesses and shares the data, as well as doubts about compliance with UK data‑protection regulations. While the technology promises improved care coordination and predictive analytics, many NHS leaders argue that the risks outweigh the benefits and call for stricter oversight or alternative solutions that keep data under direct public‑sector control. The rejection highlights growing tension between innovative health‑tech vendors and the NHS’s commitment to safeguarding confidential patient information.

תוכן זה נוצר על ידי בינה מלאכותית.